“lien enforcement notice” has the meaning ascribed to it in Article 35 (Enforcement of the Company’s lien).
“Market Price” means the market value of the A Ordinary Shares which shall be deemed to be the market price of a Common Share at the close of business on the date immediately preceding the date of the Transfer Notice.
“Merger Agreement” means the agreement and plan of merger dated 6 April 2021 entered into between the Company, CAH and Merger Sub (as amended on 19 August 2021 and 27 August 2021 and from time to time)
“Merger Sub” means LumiraDx Merger Sub, Inc.
“Morningside” means Morningside Venture Investments Limited and MVIL, LLC.
“Nasdaq” means Nasdaq Global Select Market (or other similar national quotation system of the Nasdaq Stock Market).
“ordinary resolution” means a resolution that is described as such in its terms passed by a simple majority of such shareholders as, being entitled to do so, vote in person or by proxy at a duly convened general meeting of the Company.
“Other Indemnitors” means persons or entities other than the Company that may provide indemnification, advancement of expenses and/or insurance to the Indemnified Persons in connection with such Indemnified Persons’ involvement in the management of the Company.
“paid” means paid or credited as paid.
“participate”, in relation to a directors’ meeting, has the meaning ascribed to it in Article 21 (Participation in directors’ meetings).
“partly paid” in relation to a share, means that part of that share’s par value or any premium at which it was issued that has not been paid to the Company.
“person” includes any individual, firm, corporation, body corporate, association, partnership, trust, unincorporated association, employee representative body, government or state or agency or department thereof, executors, administrators or successors in title (whether or not having a separate legal personality).
“persons entitled” has the meaning ascribed to it in Article 60.1 (Authority to capitalise and appropriation of capitalised sum).
“Pharmakon Warrants” means the warrants to be issued by the Company to BioPharma Credit Investments V (Master) LP and BPCR Limited Partnership pursuant to a warrant instrument dated 28 September 2021.
“Privileged Relation” means in relation to a shareholder, the spouse, civil partner or widow, widower or surviving civil partner of the shareholder and/or the shareholder’s children and/or grandchildren (including step and adopted children and their issue and step and adopted children of the shareholder’s children).
“proxy notice” has the meaning ascribed to it in Article 73 (Content of proxy notices).
“relevant director” means any director or former director of the Company or any associated company.
“relevant loss” means any costs, charges, losses, expenses and liabilities which have been or may be incurred by a relevant director, Secretary or other officer in the actual or purported
5